The Inflammatory Bowel Disease Clinical Decision Support Tool (IBD CDST) is a web-based tool that providers can use to help predict a patient’s response to a biologic or targeted therapy before they start it. A true point-of-care tool, the IBD CDST was developed and validated by leaders at the forefront of IBD and data science. Access this free tool anywhere on all your devices and take advantage of what data science can do for your patients. Streamline your shared decision-making, reduce guesswork, and help your patients improve faster when you make your treatment decisions with the data-backed confidence the IBD CDST can provide for you and your patients.

Take advantage of free features such as session history, a resource library, CME, risk assessment, and response prediction.

Enjoy unlimited access by clicking the "Launch Course" button above.

Commercial support:

This CDST is supported by educational grants from Takeda Pharmaceuticals U.S.A. and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC both Johnson & Johnson Companies.

Sponsor:

AGA has officially endorsed this Clinical Decision Support Tool.